[go: up one dir, main page]

AU2001250922A1 - Secreting products from skin by adeno-associated virus (aav) gene transfer - Google Patents

Secreting products from skin by adeno-associated virus (aav) gene transfer

Info

Publication number
AU2001250922A1
AU2001250922A1 AU2001250922A AU5092201A AU2001250922A1 AU 2001250922 A1 AU2001250922 A1 AU 2001250922A1 AU 2001250922 A AU2001250922 A AU 2001250922A AU 5092201 A AU5092201 A AU 5092201A AU 2001250922 A1 AU2001250922 A1 AU 2001250922A1
Authority
AU
Australia
Prior art keywords
aav
adeno
skin
gene transfer
associated virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001250922A
Other languages
English (en)
Inventor
Paul L. Hermonat
Yong Liu
Michael Mane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Arkansas at Little Rock
Original Assignee
University of Arkansas at Fayetteville
University of Arkansas at Little Rock
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Arkansas at Fayetteville, University of Arkansas at Little Rock filed Critical University of Arkansas at Fayetteville
Publication of AU2001250922A1 publication Critical patent/AU2001250922A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001250922A 2000-03-22 2001-03-22 Secreting products from skin by adeno-associated virus (aav) gene transfer Abandoned AU2001250922A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19109200P 2000-03-22 2000-03-22
US60191092 2000-03-22
PCT/US2001/009143 WO2001071018A2 (fr) 2000-03-22 2001-03-22 Produits de secretion de la peau par transfert de gene de virus associe aux adenovirus (aav)

Publications (1)

Publication Number Publication Date
AU2001250922A1 true AU2001250922A1 (en) 2001-10-03

Family

ID=22704106

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001250922A Abandoned AU2001250922A1 (en) 2000-03-22 2001-03-22 Secreting products from skin by adeno-associated virus (aav) gene transfer

Country Status (3)

Country Link
US (2) US6506600B2 (fr)
AU (1) AU2001250922A1 (fr)
WO (1) WO2001071018A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100418465B1 (ko) * 2001-01-15 2004-02-14 서동상 인슐린 의존성 당뇨병의 유전자 치료방법 및 그 치료용 조성물
US8088568B2 (en) 2001-11-05 2012-01-03 Medgentics, Inc. Dermal micro-organs, methods and apparatuses for producing and using the same
US8501396B2 (en) 2001-11-05 2013-08-06 Medgenics Medical Israel Ltd. Dermal micro-organs, methods and apparatuses for producing and using the same
US7468242B2 (en) 2001-11-05 2008-12-23 Medgenics, Inc. Dermal micro organs, methods and apparatuses for producing and using the same
DE20213391U1 (de) 2002-08-30 2004-01-15 Cameron Gmbh Verstellvorrichtung
EP2377404A1 (fr) * 2003-05-01 2011-10-19 Medgenics, Inc. Micro-organe dermique qui est un explant de tissus vivants
EP1755400A2 (fr) * 2004-06-18 2007-02-28 The University Of Montana Diffusion de genes a destination de cellules cochleaires a mediation par aav
WO2006047426A2 (fr) * 2004-10-22 2006-05-04 The Regents Of The University Of Michigan Compositions, procedes et systemes de preparation d'une population de cellules enrichie en cellules souches
WO2007134907A2 (fr) * 2006-05-18 2007-11-29 Bayer Schering Pharma Aktiengesellschaft Thérapie génique par gm-csf destinée à traiter la maladie de crohn à l'aide d'un système d'expression régulée amélioré
US9127084B2 (en) 2006-09-14 2015-09-08 Medgenics Medical Israel Ltd. Long lasting drug formulations
US8454948B2 (en) 2006-09-14 2013-06-04 Medgenics Medical Israel Ltd. Long lasting drug formulations
KR101470472B1 (ko) 2006-09-14 2014-12-09 메드제닉스 메디칼 이스라엘 리미티드 장기 지속형 약물 제형
CN105073141A (zh) * 2013-02-01 2015-11-18 詹尼斯费尔公司 用于将基因递送到细胞的功能化dna树状聚合物
EP2976109B1 (fr) 2013-03-21 2018-07-25 Genisphere, LLC Administration cellulaire d'agents intercalants de l'adn
JP7366541B2 (ja) 2016-02-19 2023-10-23 コード バイオセラピューティクス インコーポレイテッド 核酸キャリア及び治療上の使用方法
JPWO2024080311A1 (fr) * 2022-10-12 2024-04-18

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987000201A1 (fr) * 1985-07-05 1987-01-15 Whitehead Institute For Biomedical Research Cellules epitheliales exprimant un materiau genetique etranger
US5587308A (en) * 1992-06-02 1996-12-24 The United States Of America As Represented By The Department Of Health & Human Services Modified adeno-associated virus vector capable of expression from a novel promoter
IT1291135B1 (it) 1997-04-08 1998-12-29 Angeletti P Ist Richerche Bio Vettori ricombinanti utilizzabili in terapia genica
ES2313784T3 (es) * 1998-05-28 2009-03-01 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Vector aav5 y usos del mismo.

Also Published As

Publication number Publication date
US20030104575A1 (en) 2003-06-05
US20020001580A1 (en) 2002-01-03
WO2001071018A2 (fr) 2001-09-27
US6506600B2 (en) 2003-01-14
WO2001071018A3 (fr) 2002-06-13

Similar Documents

Publication Publication Date Title
AU2001250922A1 (en) Secreting products from skin by adeno-associated virus (aav) gene transfer
AU2002360291A1 (en) Adeno-associated virus (aav) serotype 8 sequences
AU2001265187A1 (en) Chimeric viral vectors for gene therapy
AU2001286643A1 (en) Gene discovery using microarrays
AU2002359284A1 (en) Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
AU769385C (en) Virus envelope vector for gene transfer
AU3358999A (en) Chimeric adenoviral vectors for targeted gene delivery
AU3369900A (en) Gene silencing
AU2002219841A1 (en) Vectors for conditional gene inactivation
AU2003253595A1 (en) Methods for the production of chimeric adeno-associated virus (aav) vectors, compositions of chimeric aav vectors, and methods of use thereof
AU2002325683A1 (en) Recombinant vector derived from adeno-associated virus for gene therapy
AU5886300A (en) Rewards based viral marketing system
AU7487200A (en) Virtual environment product placement
AU4671300A (en) The use of adeno-associated virus (aav) deliver cytoprotective genes
AU2001292125A1 (en) Genetic factors affecting the outcome of viral infections
AU2002347813A1 (en) Chimeric viral vectors for gene therapy
AU2002315502A1 (en) Sunless tanning cream
AU2002305453A1 (en) Trans-viral vector mediated gene transfer to the retina
AU2001242625A1 (en) Gene sequence
AU2001247444A1 (en) Erbeta-mediated gene expression
AU7567101A (en) Gene expression system
AU2002224845A1 (en) Viral expression system
AU2457900A (en) Duplex printing system
MXPA01012500A (es) Productos para terapia de gen.
AU2002222935A1 (en) Polycomb gene zmfie2 from maize